• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1074250-18
Device Problems Peeled/Delaminated (1454); Failure to Advance (2524)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/04/2014
Event Type  malfunction  
Event Description
It was reported that the procedure was treating a heavily tortuous, heavily calcified, 90% stenosed, de novo lesion in the proximal to mid left anterior descending coronary artery.The 2.5x18 xience xpedition stent delivery system (sds) was advanced; however, failed to cross due to the patient anatomy.Pre-dilatation was performed several times and the sds was advanced again, but still failed to cross the lesion.The device was removed from the anatomy and a non-abbott sds was used to complete the procedure.It was noted by the physician that the polymer on the stent implant may be coming off.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
(b)(4).Evaluation summary: the device was returned for analysis.The peeling was able to be confirmed.The failure to advance could not be replicated in a testing environment as it was based on operational circumstances.Based on a visual and dimensional inspection of the returned device, there is no indication of a product deficiency.A review of the lot history record revealed no non-conformances that would have contributed to the reported event.A query/review of the complaint history of the reported lot did not indicate a manufacturing issue.Based on the reviewed information, no product deficiency was identified.
 
Manufacturer Narrative
(b)(4).The device was received.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer (Section G)
CLONMEL, IRELAND REG# 9616693
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key3962092
MDR Text Key4557891
Report Number2024168-2014-04832
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 07/04/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/21/2016
Device Catalogue Number1074250-18
Device Lot Number4011641
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer07/15/2014
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/05/2014
Initial Date FDA Received07/28/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received08/12/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-